Full data view for gene TSC2

The curator’s expert opinion on the classification of a variant, can be found in the
SUMMARY record. Regarding the classification, please note that where there are several
records of the same variant, the classification of that variant may differ depending on the
submitter’s conclusion.
Information The variants shown are described using the NM_000548.3 transcript reference sequence.

3 entries on 1 page. Showing entries 1 - 3.
Legend   How to query  

Effect     

Exon     

AscendingDNA change (cDNA)     

RNA change     

Protein     

P-domain     

Predict-BioInf     

Allele     

Classification method     

Clinical classification     

DNA change (genomic) (hg19)     

DNA change (hg38)     

Published as     

ISCN     

DB-ID     

Variant remarks     

Reference     

ClinVar ID     

dbSNP ID     

Origin     

Segregation     

Frequency     

Re-site     

VIP     

Methylation     

Template     

Technique     

Tissue     

Remarks     

Disease     

ID_report     

Reference     

Remarks     

Gender     

Consanguinity     

Country     

Population     

Age at death     

VIP     

Data_av     

Treatment     

Panel size     

Owner     
+/. 37 c.4726_4782del - p.Thr1576_Leu1594del GAP domain - Unknown - NA g.2136257_2136313del g.2086256_2086312del - - TSC2_000608 diffuse cytoplasmic signal; phosphorylation of S6K T389 significantly higher than wild type TSC2 indicating inability of variant to inhibit mTOR activity; signal for TSC2 variant significantly less than wild type indicating steady state expression of variant reduced and therefore unstable PubMed: Hoogeveen-Westerveld, 2011 - - In vitro (cloned) - - - - - - - - - - - - - - - - - - - - - - -
+/. 37 c.4726_4782del r.(?) p.(Thr1576_Leu1594del) GAP domain - Maternal (confirmed) - pathogenic g.2136257_2136313del g.2086256_2086312del 4675del57 (4726del57); 1553del19 (1576del19); c.4726_4783del, (p.1575del19/1552del19) - TSC2_000608 57bp (19 amino acids) in-frame deletion; DNA change described in Hoogeveen-Westerveld (2011) off by one; also reported as pathogenicity probable; found with TSC c.482-3C>T originally Kwiatkowski database, PubMed: Sancak, 2005, PubMed: Coevoets, 2009, PubMed: Hoogeveen-Westerveld, 2011 - - Germline - - AluI-, -TaqI - - DNA SEQ Blood - TSC - originally Kwiatkowski database, PubMed: Sancak, 2005, PubMed: Coevoets, 2009, PubMed: Hoogeveen-Westerveld, 2011 index (TS affected) and 2 other family members have the same 57bp deletion; no clinical information on the family members; index also has TSC2 c.482-3C>T ? - - - - - - - 1 Rosemary Ekong
+?/+? 37 c.4726_4782del r.(?) p.(Thr1576_Leu1594del) GAP domain - Unknown - likely pathogenic (dominant) g.2136257_2136313del g.2086256_2086312del - - TSC2_000608 57bp (in-frame) deletion of ACGGGCCTGGGCCGGCTCATCGAGCTGAAGGACTGCCAGCCGGACAAGGTGTACCTG - - - SUMMARY record - - AluI-, TaqI- - - - - - - - - - - - - - - - - - - - -
Legend   How to query  

Assessment of functional consequences - Our conclusions on the functional consequences of variants are based on the type of variant, results of in vitro functional tests (doi: 10.1002/humu.21451; doi: 10.1002/humu.22202; doi: 10.1002/humu.23963), population frequencies, output from in silico splice site prediction algorithms, and any clinical/family data available to us. We also have output from protein prediction programs in this database for comparison purposes and they are not considered in our assessment of pathogenicity. PolyPhen Predictions - Note that these results are from PolyPhen-2 and only the HumDiv classification is shown.


Screenscraping/webscraping (interacting with LOVD using scripts to download data) is strictly prohibited.
Use our APIs to retrieve data.